GlassScriptPhysician profile
John Foley
NPI 1053381517
$2,590.50
in general payments reported to CMS, 2019-2025
28 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $857 · 2020: $117 · 2021: $47.04 · 2022: $308 · 2023: $726 · 2024: $424 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,262.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $406.04 | 2019-2024 | Myrbetriq, Xtandi, Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $285.97 | 2023-2025 | |
| Janssen Biotech, INC. | $280.47 | 2019-2024 | Erleada |
| Abbvie INC. | $259.63 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $205.28 | 2019-2024 | Xiaflex, Aveed |
| Pfizer INC. | $175.87 | 2019-2023 | |
| Dendreon Pharmaceuticals LLC | $164.59 | 2019-2023 | Provenge |
| Boston Scientific Corporation | $138.27 | 2019-2024 | Ams 700 |
| Coloplast Corp | $122.44 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $94.02 | 2023-2024 | Gemtesa |
| Tolmar, INC. | $49.99 | 2023-2024 | |
| Progenics Pharmaceuticals, INC. | $42.62 | 2024 | |
| Merck Sharp & Dohme LLC | $40.85 | 2021-2022 | |
| Convatec INC. | $36.08 | 2023 | |
| Olympus America INC. | $34.02 | 2019-2023 | Itind System |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $32.09 | 2025 | |
| Profound Medical Corp. | $27.66 | 2025 | Tulsa-Pro |
| Neotract INC. | $25.99 | 2020 | |
| Myovant Sciences INC. | $24.55 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $24.00 | 2019 | |
| Photocure INC | $21.55 | 2019 | |
| Endo USA, INC. | $16.95 | 2024 | Xiaflex, Aveed |
| Amgen INC. | $16.69 | 2019 | |
| Procept Biorobotics Corporation | $16.09 | 2023 | Aquabeam Robotic System |
| Emd Serono, INC. | $15.61 | 2019 | |
| Allergan, INC. | $13.27 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.37 | 2019 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Foley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.